Francis Medical Expands Commercial Use of Vanquish System in U.S. Southeast

According to a recent LinkedIn post from Francis Medical, the company’s Vanquish Water Vapor Ablation System is seeing expanded commercial use in the Southeastern United States. The post cites recent prostate procedures using Vanquish in Atlanta, Georgia, performed by urologists at Advanced Urology facilities.

The company’s LinkedIn post highlights that Vanquish delivers high-energy sterile water vapor via a transurethral approach to ablate targeted prostate tissue, and notes that the system is FDA cleared and available by prescription only. For investors, broader utilization at multiple surgery centers may indicate early traction in commercial adoption, which could support revenue growth prospects and enhance Francis Medical’s competitive position in the urology devices segment.